About InvAscent
InvAscent is a private equity firm founded in 2006. It is primarily based in Hyderabad, India.
Overall InvAscent portfolio has seen 5 IPOs and 13 acquisitions, namely MediBuddy, HealthCare Global Enterprises and Oliva Clinics. A lot of funds co-invest with InvAscent, with names like TEAMFund sharing a substantial percentage of its portfolio.
InvAscent has a team of 27 people, including 5 partners.
Key Metrics
InvAscent's Portfolio
They have invested in a total of 39 companies. Their most recent investment was in Apex Hospitals (PE round) on Sep 28, 2025. Here is the most recent investment by InvAscent:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Sep 28, 2025 | PE | 1948 | - | |
Apr 17, 2025 | PE | 7609 | - | |
Jan 24, 2025 | Series A | 4559 | - | |
Apr 30, 2024 | Unattributed | 4481 |
Here is the portfolio snapshot of InvAscent:
Investments by Year
The maximum number of investments were made in 2022
Team profile of InvAscent
InvAscent has a team of 27 members including 5 Partners and 3 Principals located in India. InvAscent's team does not sit on the board of any company as of now.Here is a list of top team members in InvAscent:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Mumbai | - | ||
Partner | Hyderabad | - | ||
Partner | Hyderabad | - | ||
Partner | India | Symbiotec, Maiva Pharma and 2 more | ||
Partner | Hyderabad | - | - | |
Principal | India | - | ||
Principal | Ahmedabad | - | ||
Principal | Ahmedabad | - | - | |
Advisor | Bengaluru | - | - |
Co-investors of InvAscent
Over the past 20 years, 15 investors have co-invested in InvAscent's portfolio companies.
- Top Co-investors of InvAscent: 15 investors entered a company along with InvAscent. These include investors like TEAMFund (1 company).
InvAscent News
•
InvAscent writes bigger cheques in pharma as rising costs reset capital needsMint•Jan 29, 2026•InvAscent
•
InvAscent Exits Animal Pharma Firm, Sells Stake to Family OfficeVCCircle•Oct 08, 2025•InvAscent, Merck Animal Health
•
Somerset Indus Capital Partners exits Apex Hospitals with 4x returnMoneycontrol•Sep 30, 2025•Apexhospitalvja, Somerset Indus Capital Partners, InvAscent, Apex Hospitals
•
InvAscent-backed Malladi Drugs plans Rs 1,200-crore IPO, in talks with banksMoneycontrol•Sep 23, 2025•Malladi, InvAscent
•
Drug firm Aizant to soon get binding bids for controlling stake in $350-mn dealMint•Jul 30, 2025•InvAscent, Aizant
•
SRV Hospitals gets Rs. 140 crore from InvAscent for expansionMoneycontrol•Apr 17, 2025•SRV Hospitals, InvAscent
•
•
InvAscent Seeks Exit from Animal Pharma Portfolio via Secondary TransactionVCCircle•Apr 14, 2025•InvAscent, Animal Pharmaceuticals
•
InvAscent plots an exit move as healthcare portfolio firm’s IPO plan takes shapeVCCircle•Mar 20, 2025•InvAscent
•
InvAscent plots an exit move as healthcare portfolio firm’s IPO plan takes shapeVCCircle•Mar 20, 2025•InvAscent
